PATENT CLAIM ANALYSIS

Application Number: 16023102
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide and solvates, crystalline forms and amorphous forms thereof, to the use of said compositions as a medicament; and to processes for the preparation of said compositions.

Claim (Index 57):
The method of  claim 56 , wherein the condition is cancer.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.37838
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13463499', '14698151', '13391440', '14197476', '13414369']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7417338041706252
- 35 USC 102 Novelty (BERT): 0.5149354973564458
- Combined Prediction Score: 0.7190539734892073
- Mean Citation Score: 219.52810600000004
- Max Citation Score: 251.7257
- Similarity Product: 146.63216597143412

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test